Review article · 2022 · Open access

Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases

Fangyu Yang, Jianjiang Xue, Guixue Wang, Qizhi Diao

Frontiers in Pharmacology, 13, 999404 · Published 12 September 2022 · DOI 10.3389/fphar.2022.999404

Open PDFView at the publisherCite this paper

In brief

“Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases” is a 2022 review article by Fangyu Yang and 3 co-authors, published in Frontiers in Pharmacology. OpenAlex counts 118 citations as of 19 November 2026, which puts it in the top 1% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Pharmacology.

Citations
118
Most cited in
2025 (49)
Field-weighted impact
1.21
References
102
Authors
4

Abstract

Cardiovascular disease is the most common health problem worldwide and remains the leading cause of morbidity and mortality. Despite recent advances in the management of cardiovascular diseases, pharmaceutical treatment remains suboptimal because of poor pharmacokinetics and high toxicity. However, since being harnessed in the cancer field for the delivery of safer and more effective chemotherapeutics, nanoparticle-based drug delivery systems have offered multiple significant therapeutic effects in treating cardiovascular diseases. Nanoparticle-based drug delivery systems alter the biodistribution of therapeutic agents through site-specific, target-oriented delivery and controlled drug release of precise medicines. Metal-, lipid-, and polymer-based nanoparticles represent ideal materials for use in cardiovascular therapeutics. New developments in the therapeutic potential of drug delivery using nanoparticles and the application of nanomedicine to cardiovascular diseases are described in this review. Furthermore, this review discusses our current understanding of the potential role of nanoparticles in metabolism and toxicity after therapeutic action, with a view to providing a safer and more effective strategy for the treatment of cardiovascular disease.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yang, F., Xue, J., Wang, G., & Diao, Q. (2022). Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases. Frontiers in Pharmacology, 13, 999404. https://doi.org/10.3389/fphar.2022.999404

MLA 9

Yang, Fangyu, et al. “Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases.” Frontiers in Pharmacology, vol. 13, 2022, p. 999404. https://doi.org/10.3389/fphar.2022.999404.

Chicago

Yang, Fangyu, Jianjiang Xue, Guixue Wang, and Qizhi Diao. 2022. “Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases.” Frontiers in Pharmacology 13: 999404. https://doi.org/10.3389/fphar.2022.999404.

Harvard

Yang, F. et al. (2022) ‘Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases’, Frontiers in Pharmacology, 13, p. 999404. doi:10.3389/fphar.2022.999404.

IEEE

F. Yang, J. Xue, G. Wang, and Q. Diao, “Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases,” Frontiers in Pharmacology, vol. 13, p. 999404, 2022, doi: 10.3389/fphar.2022.999404.

BibTeX

@article{yang2022nanoparticle,
  title     = {{Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases}},
  author    = {Yang, Fangyu and Xue, Jianjiang and Wang, Guixue and Diao, Qizhi},
  journal   = {Frontiers in Pharmacology},
  year      = {2022},
  volume    = {13},
  pages     = {999404},
  doi       = {10.3389/fphar.2022.999404},
  url       = {https://doi.org/10.3389/fphar.2022.999404}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20231111
20242323
20254949
20263535

Its field-weighted citation impact is 1.21: it has been cited 1.21 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • nanoparticle drug delivery
  • cardiovascular disease
  • nanomedicine
  • metal nanoparticles
  • lipid nanoparticles
  • polymeric nanoparticles
  • targeted drug delivery
  • controlled drug release

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Yang, F., Xue, J., Wang, G., & Diao, Q. (2022). Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases. Frontiers in Pharmacology, 13, 999404. https://doi.org/10.3389/fphar.2022.999404

How many times has this paper been cited?

118 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Pharmacology: sign in and open the PDF from this page.

Who wrote this paper?

Fangyu Yang, Jianjiang Xue, Guixue Wang, Qizhi Diao.

What is the DOI of this paper?

10.3389/fphar.2022.999404, permanently at https://doi.org/10.3389/fphar.2022.999404. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.